Fillmore Capital Partners

AlixaRx receives capital infusion

AlixaRx has received a $100 million investment from Fillmore Capital Partners and be spun off from Drumm Corp., the companies said Monday.

(Oval) Office politics and private equity

(Oval) Office politics and private equity


It was nearly four and a half years ago that The New York Times caused quite a stir in this sector. That's when the self-proclaimed newspaper of record ran a largely unflattering piece about private equity firms that own nursing homes.